Results 141 to 150 of about 288,727 (306)

Tyrosine kinase – Role and significance in Cancer

International Journal of Medical Sciences, 2004
Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli.
doaj  

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

Advanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård, Tatiana Bobrova, Amalie Leinebø, Thibault Leray, Shayamita Ghosh, Lorena García‐Hevia, Chiara Puccinelli, Lorenzo Riccio, Jacopo Sorani, Davide Bonifazi, Julien Caumartin, Emmanuel Donnadieu, Florence Gazeau, Roland Hischier, Else Marit Inderberg, Mónica L. Fanarraga, Maria Loustau, Bernd Nowack, Sébastien Wälchli, Cécilia Ménard‐Moyon   +19 more
wiley   +1 more source

Therapeutic Potential of Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer. [PDF]

Curr Oncol Rep
Gangadaran P, Sankarapandian V, Arun R, ArulJothi KN, Rajendran RL, Oh JM, Kumaraswamy A, Gurunagarajan S, Ahn BC.   +8 more
europepmc   +1 more source

Extramedullary Involvement by Chronic Myelogeneous Leukemia in Five Patients With Unusual Clinicopathologic Features: A Review of the Effectiveness of Tyrosine Kinase Inhibitors

, 2016
Abha Soni, Ravikumar Paluri, Taylor Deal, Deniz Peker   +3 more
openalex   +2 more sources

Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy [PDF]

, 2018
Kazutoshi Komiya, Chiho Nakashima, Tomomi Nakamura, Haruki Hirakawa, Tomonori Abe, Shinsuke Ogusu, Koichiro Takahashi, Yuji Takeda, Yoshiaki Egashira, Shinya Kimura, Naoko Sueoka‐Aragane   +10 more
openalex   +1 more source

MEOX1 Coordinates Autocrine‐Paracrine Programs via SPHK1/S1P to Promote Lymph Node Metastasis in Ovarian Cancer

Advanced Science, EarlyView.
In ovarian cancer, MEOX1 activates the SPHK1/S1P pathway to promote both tumor progression and tumor–stroma crosstalk. MEOX1‐dependent signaling drives CAF activation, enhances VEGF‐C expression, and stimulates lymphangiogenesis, ultimately facilitating lymph node metastasis.
Jiajia Li, Xiuling Zhi, Qianhan Lin, Yating Sun, Yihua Sun, Zulimire Abudousalamu, Mengyang Xue, Chang Zheng, Xiaotian Li, Liangqing Yao, Mo Chen   +10 more
wiley   +1 more source

Colorectal cancer cells respond differentially to autophagy induced by tyrosine kinase inhibitors. [PDF]

Sci Rep
Louadj L, Gerotziafas G, Sabbah M, Larsen AK.   +3 more
europepmc   +1 more source

[Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations].

, 2016
Qunhui Wang, Hua Zheng, Fanbin Hu, Hongmei Zhang, Ying Hu, Jie Li, Tongmei Zhang, Zan Liu, Baohua Lu, Aimin Hu, Baolan Li   +10 more
openalex   +2 more sources

FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma

Advanced Science, EarlyView.
ABSTRACT While targeted therapies have improved outcomes in lung adenocarcinoma (LUAD), many patients still lack targetable mutations. Here, we identified alpha‐L‐fucosidase 2 (FUCA2) as a crucial driver of LUAD by preventing cellular senescence. Mechanistically, through the restriction of fucosyltransferase 3 (FUT3)‐mediated α‐1,3‐fucosylation of ...
Lu Chen, Jintao Guo, Fei Li, Mingjie Gao, Runyang Li, Zhaozhang Huang, Yaolin Zheng, Chunyi Gao, Jihuan Hou, Qiang Yu, Bowen Zheng, Xuemei Chen, Wenqing Zhang, Xiaoting Hong, Yali Zheng, Daxuan Wang, Qiyuan Li, Tianhui Hu, Yan‐yan Zhan   +18 more
wiley   +1 more source

EGFR Mutations and Tyrosine Kinase Inhibitors: Structural Insights and Therapeutic Advances. [PDF]

ACS Omega
Manoj MV, Mupparaju V RB, Thakur A, Sasidharan Pillai AK.   +3 more
europepmc   +1 more source